In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production

Detalhes bibliográficos
Autor(a) principal: Pereira, Tiago B.
Data de Publicação: 2014
Outros Autores: Silva, Luiz Francisco Rocha e, Amorim, Rodrigo C.N., Melo, Márcia R.S., Zacardi de Souza, Rita C., Eberlin, M. N., Lima, Emerson Silva, Vasconcellos, Marne Carvalho de, Pohlit, Adrian Martin
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional do INPA
Texto Completo: https://repositorio.inpa.gov.br/handle/1/15981
Resumo: Background: Carapa guianensis is a cultivable tree used by traditional health practitioners in the Amazon region to treat several diseases and particularly symptoms related to malaria. Abundant residual pressed seed material (RPSM) results as a by-product of carapa or andiroba oil production. The objective of this study was to evaluate the in vitro and in vivo anti-malarial activity and cytotoxicity of limonoids isolated from C. guaianensis RPSM.Methods. 6-acetoxyepoxyazadiradione (1), andirobin (2), 6-acetoxygedunin (3) and 7-deacetoxy-7-oxogedunin (4) (all isolated from RPSM using extraction and chromatography techniques) and 6-hydroxy-deacetylgedunin (5) (prepared from 3) were evaluated using the micro test on the multi-drug-resistant Plasmodium falciparum K1 strain. The efficacy of limonoids 3 and 4 was then evaluated orally and subcutaneously in BALB/c mice infected with chloroquine-sensitive Plasmodium berghei NK65 strain in the 4-day suppressive test.Results: In vitro, limonoids 1-5 exhibited median inhibition concentrations (IC50) of 20.7-5.0 μM, respectively. In general, these limonoids were not toxic to normal cells (MRC-5 human fibroblasts). In vivo, 3 was more active than 4. At oral doses of 50 and 100 mg/kg/day, 3 suppressed parasitaemia versus untreated controls by 40 and 66%, respectively, evidencing a clear dose-response.Conclusion: 6-acetoxygedunin is an abundant natural product present in C. guianensis residual seed materials that exhibits significant in vivo anti-malarial properties. © 2014 Pereira et al.; licensee BioMed Central Ltd.x.
id INPA-2_36a2a8d3c031a6272cbc1c0e0ac2fe16
oai_identifier_str oai:repositorio:1/15981
network_acronym_str INPA-2
network_name_str Repositório Institucional do INPA
repository_id_str
spelling Pereira, Tiago B.Silva, Luiz Francisco Rocha eAmorim, Rodrigo C.N.Melo, Márcia R.S.Zacardi de Souza, Rita C.Eberlin, M. N.Lima, Emerson SilvaVasconcellos, Marne Carvalho dePohlit, Adrian Martin2020-05-21T20:06:20Z2020-05-21T20:06:20Z2014https://repositorio.inpa.gov.br/handle/1/1598110.1186/1475-2875-13-317Background: Carapa guianensis is a cultivable tree used by traditional health practitioners in the Amazon region to treat several diseases and particularly symptoms related to malaria. Abundant residual pressed seed material (RPSM) results as a by-product of carapa or andiroba oil production. The objective of this study was to evaluate the in vitro and in vivo anti-malarial activity and cytotoxicity of limonoids isolated from C. guaianensis RPSM.Methods. 6-acetoxyepoxyazadiradione (1), andirobin (2), 6-acetoxygedunin (3) and 7-deacetoxy-7-oxogedunin (4) (all isolated from RPSM using extraction and chromatography techniques) and 6-hydroxy-deacetylgedunin (5) (prepared from 3) were evaluated using the micro test on the multi-drug-resistant Plasmodium falciparum K1 strain. The efficacy of limonoids 3 and 4 was then evaluated orally and subcutaneously in BALB/c mice infected with chloroquine-sensitive Plasmodium berghei NK65 strain in the 4-day suppressive test.Results: In vitro, limonoids 1-5 exhibited median inhibition concentrations (IC50) of 20.7-5.0 μM, respectively. In general, these limonoids were not toxic to normal cells (MRC-5 human fibroblasts). In vivo, 3 was more active than 4. At oral doses of 50 and 100 mg/kg/day, 3 suppressed parasitaemia versus untreated controls by 40 and 66%, respectively, evidencing a clear dose-response.Conclusion: 6-acetoxygedunin is an abundant natural product present in C. guianensis residual seed materials that exhibits significant in vivo anti-malarial properties. © 2014 Pereira et al.; licensee BioMed Central Ltd.x.Volume 13, Número 1Attribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccess6alpha Acetoxyepoxyazadiradione6alpha Acetoxygedunin6alpha Hydroxydeacetylgedunin7 Deacetoxy 7 OxogeduninAndirobinAntimalarial AgentLimonoidPlant ExtractUnclassified DrugAntimalarial AgentLimonoidPlant ExtractAnimals ExperimentAnimals ModelAntimalarial ActivityCarapa GuianensisControlled StudyDose ResponseDrug CytotoxicityDrug EfficacyDrug ScreeningFibroblastHumanHuman CellIc 50In Vitro StudyIn Vivo StudyMedicinal PlantMeliaceaeMinimum Inhibitory ConcentrationMouseNonhumanSeed PlantPlasmodium Berghei InfectionPlasmodium FalciparumAnimalsBagg Albino MouseCell LineChemistryDrug EffectsFemaleMalariaMeliaceaePlasmodium BergheiAnimalAntimalarialsCell LineFemaleHumansInhibitory Concentration 50LimoninsMalariaMeliaceaeMiceMice, Inbred Balb CPlant ExtractsPlasmodium BergheiPlasmodium FalciparumSeedsIn vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil productioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleMalaria Journalengreponame:Repositório Institucional do INPAinstname:Instituto Nacional de Pesquisas da Amazônia (INPA)instacron:INPAORIGINALartigo-inpa.pdfartigo-inpa.pdfapplication/pdf406407https://repositorio.inpa.gov.br/bitstream/1/15981/1/artigo-inpa.pdfcc5bb38251c7ca8c3297dd6e26f4691cMD511/159812020-05-21 17:09:14.276oai:repositorio:1/15981Repositório de PublicaçõesPUBhttps://repositorio.inpa.gov.br/oai/requestopendoar:2020-05-21T21:09:14Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)false
dc.title.en.fl_str_mv In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production
title In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production
spellingShingle In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production
Pereira, Tiago B.
6alpha Acetoxyepoxyazadiradione
6alpha Acetoxygedunin
6alpha Hydroxydeacetylgedunin
7 Deacetoxy 7 Oxogedunin
Andirobin
Antimalarial Agent
Limonoid
Plant Extract
Unclassified Drug
Antimalarial Agent
Limonoid
Plant Extract
Animals Experiment
Animals Model
Antimalarial Activity
Carapa Guianensis
Controlled Study
Dose Response
Drug Cytotoxicity
Drug Efficacy
Drug Screening
Fibroblast
Human
Human Cell
Ic 50
In Vitro Study
In Vivo Study
Medicinal Plant
Meliaceae
Minimum Inhibitory Concentration
Mouse
Nonhuman
Seed Plant
Plasmodium Berghei Infection
Plasmodium Falciparum
Animals
Bagg Albino Mouse
Cell Line
Chemistry
Drug Effects
Female
Malaria
Meliaceae
Plasmodium Berghei
Animal
Antimalarials
Cell Line
Female
Humans
Inhibitory Concentration 50
Limonins
Malaria
Meliaceae
Mice
Mice, Inbred Balb C
Plant Extracts
Plasmodium Berghei
Plasmodium Falciparum
Seeds
title_short In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production
title_full In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production
title_fullStr In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production
title_full_unstemmed In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production
title_sort In vitro and in vivo anti-malarial activity of limonoids isolated from the residual seed biomass from Carapa guianensis (andiroba) oil production
author Pereira, Tiago B.
author_facet Pereira, Tiago B.
Silva, Luiz Francisco Rocha e
Amorim, Rodrigo C.N.
Melo, Márcia R.S.
Zacardi de Souza, Rita C.
Eberlin, M. N.
Lima, Emerson Silva
Vasconcellos, Marne Carvalho de
Pohlit, Adrian Martin
author_role author
author2 Silva, Luiz Francisco Rocha e
Amorim, Rodrigo C.N.
Melo, Márcia R.S.
Zacardi de Souza, Rita C.
Eberlin, M. N.
Lima, Emerson Silva
Vasconcellos, Marne Carvalho de
Pohlit, Adrian Martin
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pereira, Tiago B.
Silva, Luiz Francisco Rocha e
Amorim, Rodrigo C.N.
Melo, Márcia R.S.
Zacardi de Souza, Rita C.
Eberlin, M. N.
Lima, Emerson Silva
Vasconcellos, Marne Carvalho de
Pohlit, Adrian Martin
dc.subject.eng.fl_str_mv 6alpha Acetoxyepoxyazadiradione
6alpha Acetoxygedunin
6alpha Hydroxydeacetylgedunin
7 Deacetoxy 7 Oxogedunin
Andirobin
Antimalarial Agent
Limonoid
Plant Extract
Unclassified Drug
Antimalarial Agent
Limonoid
Plant Extract
Animals Experiment
Animals Model
Antimalarial Activity
Carapa Guianensis
Controlled Study
Dose Response
Drug Cytotoxicity
Drug Efficacy
Drug Screening
Fibroblast
Human
Human Cell
Ic 50
In Vitro Study
In Vivo Study
Medicinal Plant
Meliaceae
Minimum Inhibitory Concentration
Mouse
Nonhuman
Seed Plant
Plasmodium Berghei Infection
Plasmodium Falciparum
Animals
Bagg Albino Mouse
Cell Line
Chemistry
Drug Effects
Female
Malaria
Meliaceae
Plasmodium Berghei
Animal
Antimalarials
Cell Line
Female
Humans
Inhibitory Concentration 50
Limonins
Malaria
Meliaceae
Mice
Mice, Inbred Balb C
Plant Extracts
Plasmodium Berghei
Plasmodium Falciparum
Seeds
topic 6alpha Acetoxyepoxyazadiradione
6alpha Acetoxygedunin
6alpha Hydroxydeacetylgedunin
7 Deacetoxy 7 Oxogedunin
Andirobin
Antimalarial Agent
Limonoid
Plant Extract
Unclassified Drug
Antimalarial Agent
Limonoid
Plant Extract
Animals Experiment
Animals Model
Antimalarial Activity
Carapa Guianensis
Controlled Study
Dose Response
Drug Cytotoxicity
Drug Efficacy
Drug Screening
Fibroblast
Human
Human Cell
Ic 50
In Vitro Study
In Vivo Study
Medicinal Plant
Meliaceae
Minimum Inhibitory Concentration
Mouse
Nonhuman
Seed Plant
Plasmodium Berghei Infection
Plasmodium Falciparum
Animals
Bagg Albino Mouse
Cell Line
Chemistry
Drug Effects
Female
Malaria
Meliaceae
Plasmodium Berghei
Animal
Antimalarials
Cell Line
Female
Humans
Inhibitory Concentration 50
Limonins
Malaria
Meliaceae
Mice
Mice, Inbred Balb C
Plant Extracts
Plasmodium Berghei
Plasmodium Falciparum
Seeds
description Background: Carapa guianensis is a cultivable tree used by traditional health practitioners in the Amazon region to treat several diseases and particularly symptoms related to malaria. Abundant residual pressed seed material (RPSM) results as a by-product of carapa or andiroba oil production. The objective of this study was to evaluate the in vitro and in vivo anti-malarial activity and cytotoxicity of limonoids isolated from C. guaianensis RPSM.Methods. 6-acetoxyepoxyazadiradione (1), andirobin (2), 6-acetoxygedunin (3) and 7-deacetoxy-7-oxogedunin (4) (all isolated from RPSM using extraction and chromatography techniques) and 6-hydroxy-deacetylgedunin (5) (prepared from 3) were evaluated using the micro test on the multi-drug-resistant Plasmodium falciparum K1 strain. The efficacy of limonoids 3 and 4 was then evaluated orally and subcutaneously in BALB/c mice infected with chloroquine-sensitive Plasmodium berghei NK65 strain in the 4-day suppressive test.Results: In vitro, limonoids 1-5 exhibited median inhibition concentrations (IC50) of 20.7-5.0 μM, respectively. In general, these limonoids were not toxic to normal cells (MRC-5 human fibroblasts). In vivo, 3 was more active than 4. At oral doses of 50 and 100 mg/kg/day, 3 suppressed parasitaemia versus untreated controls by 40 and 66%, respectively, evidencing a clear dose-response.Conclusion: 6-acetoxygedunin is an abundant natural product present in C. guianensis residual seed materials that exhibits significant in vivo anti-malarial properties. © 2014 Pereira et al.; licensee BioMed Central Ltd.x.
publishDate 2014
dc.date.issued.fl_str_mv 2014
dc.date.accessioned.fl_str_mv 2020-05-21T20:06:20Z
dc.date.available.fl_str_mv 2020-05-21T20:06:20Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.inpa.gov.br/handle/1/15981
dc.identifier.doi.none.fl_str_mv 10.1186/1475-2875-13-317
url https://repositorio.inpa.gov.br/handle/1/15981
identifier_str_mv 10.1186/1475-2875-13-317
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Volume 13, Número 1
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Malaria Journal
publisher.none.fl_str_mv Malaria Journal
dc.source.none.fl_str_mv reponame:Repositório Institucional do INPA
instname:Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron:INPA
instname_str Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron_str INPA
institution INPA
reponame_str Repositório Institucional do INPA
collection Repositório Institucional do INPA
bitstream.url.fl_str_mv https://repositorio.inpa.gov.br/bitstream/1/15981/1/artigo-inpa.pdf
bitstream.checksum.fl_str_mv cc5bb38251c7ca8c3297dd6e26f4691c
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)
repository.mail.fl_str_mv
_version_ 1809928874704764928